Bank & Trust Company’s Eli Lilly LLY Stock Holding History

Bank & Trust Company’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.2M	Sell	11,001 -360	-3%	-$368K	8.33%	1
2026 Q1	$10.4M	Sell	11,361 -140	-1%	-$142K	7.04%	2
2025 Q4	$12.4M	Sell	11,501 -29	-0.3%	-$27.7K	8.73%	1
2025 Q3	$8.8M	Sell	11,530 -40	-0.3%	-$29.8K	6.5%	2
2025 Q2	$9.02M	Sell	11,570 -300	-3%	-$233K	7.14%	2
2025 Q1	$9.8M	Sell	11,870 -149	-1%	-$124K	7.98%	2
2024 Q4	$9.28M	Sell	12,019 -262	-2%	-$217K	7.79%	1
2024 Q3	$10.9M	Sell	12,281 -16	-0.1%	-$14.4K	8.83%	1
2024 Q2	$11.1M	Buy	+12,297	New	+$9.84M	9.45%	1

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Sapient Capital Indianapolis, Indiana $7.64B AUM 51.51% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Bank & Trust Company's LLY Position: Q2 2026 in Review

Bank & Trust Company reduced its Eli Lilly (LLY) stake by 3.2% in Q2 2026, selling an estimated $368K and leaving 11,001 shares worth $13.2M. The position accounts for 8.33% of the portfolio, ranked #1.

Bank & Trust Company first reported a position in LLY in Q2 2024 and has held it in 9 quarters since. 2,244 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

Bank & Trust Company held 11,001 shares of Eli Lilly worth $13.2M as of Q2 2026.
Bank & Trust Company sold 360 Eli Lilly shares in Q2 2026, an estimated $368K.
Eli Lilly made up 8.33% of Bank & Trust Company's portfolio in Q2 2026, its #1 holding.
Bank & Trust Company first reported a position in Eli Lilly in Q2 2024 and has held it in 9 quarters since.
2,244 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Bank & Trust Company's 13F filing for Q2 2026, filed 10 Jul 2026.